scispace - formally typeset
M

Michael N Dalili

Researcher at University of Bristol

Publications -  13
Citations -  817

Michael N Dalili is an academic researcher from University of Bristol. The author has contributed to research in topics: Varenicline & Smoking cessation. The author has an hindex of 6, co-authored 12 publications receiving 627 citations.

Papers
More filters
Journal ArticleDOI

Internet‐based interventions for smoking cessation

TL;DR: To determine the effectiveness of Internet-based interventions for smoking cessation, whether intervention effectiveness is altered by tailoring or interactive features, and if there is a difference in effectiveness between adolescents, young adults, and adults is investigated.
Journal ArticleDOI

Meta-analysis of emotion recognition deficits in major depressive disorder.

TL;DR: The findings suggest that the ER impairment reported in the depression literature exists across all basic emotions except sadness, and the effect size is small, and previous studies have been underpowered.
Journal ArticleDOI

Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis

TL;DR: In this paper, the authors evaluated the clinical effectiveness, safety and cost-effectiveness of smoking cessation medicines and e-cigarettes in the UK and found that the combination therapies of medicines are among the most clinically effective, safe and cost effective treatment options for smokers.
Journal ArticleDOI

State anxiety and emotional face recognition in healthy volunteers

TL;DR: The experimental studies indicated reduced global (rather than emotion-specific) emotion recognition accuracy and increased interpretation bias when state anxiety was heightened, and indicated that negative effects of trait anxiety are negated when controlling for state anxiety, suggesting a mediating effect of state anxiety.
Journal ArticleDOI

Emotional recognition training modifies neural response to emotional faces but does not improve mood in healthy volunteers with high levels of depressive symptoms.

TL;DR: CBM of emotion recognition has effects on neural activity that are similar in some respects to those induced by Selective Serotonin Reuptake Inhibitors (SSRI) administration, but there is no evidence that this had any later effect on self-reported mood in an analogue sample of non-clinical volunteers with low mood.